<DOC>
	<DOC>NCT01164033</DOC>
	<brief_summary>This open-label, randomized, cross-over study will evaluate the effect of food on the pharmacokinetics of single oral doses of RO5045337 in patients with solid tumors. The anticipated time on study treatment is 3 weeks.</brief_summary>
	<brief_title>A Study of RO5045337 in Patients With Solid Tumors</brief_title>
	<detailed_description />
	<criteria>Adult patients, &gt;/=18 years of age Histologically confirmed solid tumor Life expectancy of &gt;/=12 weeks ECOG performance status of 0 or 1 Adequate bone marrow, renal and hepatic function Patients receiving any other investigational agent or therapy administered with the intention to treat their malignancy within 28 days prior to study start Patients with preexisting gastrointestinal disorder Patients with uncontrolled intercurrent illness</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>